Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By State of Finished Product (Solids, Semi-solids, and Liquids), Content (Organic Substances Isolated from Animal Origin, Organic Substances Isolated from Microorganisms, and Inorganic Substances)

No. of Pages: 135
Report Code: TIPRE00027251
Category: Life Sciences
Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Regional Analysis

6.2 Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Forecast Analysis

7. Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Analysis – by State of Finished Product

7.1 Solids
  • 7.1.1 Overview
  • 7.1.2 Solids: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Semi-solids
  • 7.2.1 Overview
  • 7.2.2 Semi-solids: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Liquids
  • 7.3.1 Overview
  • 7.3.2 Liquids: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Analysis – by Content

8.1 Organic Substances Isolated from Animal Origin
  • 8.1.1 Overview
  • 8.1.2 Organic Substances Isolated from Animal Origin: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Organic Substances Isolated from Microorganisms
  • 8.2.1 Overview
  • 8.2.2 Organic Substances Isolated from Microorganisms: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Inorganic Substances
  • 8.3.1 Overview
  • 8.3.2 Inorganic Substances : Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Asia-Pacific Analysis

9.1 Overview

9.2 Asia-Pacific
  • 9.2.1 Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.2.1.1 Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 China: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.1.1 China: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
    • 9.2.1.1.2 China: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content
  • 9.2.1.2 India: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.2.1 India: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
    • 9.2.1.2.2 India: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content
  • 9.2.1.3 Japan: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.3.1 Japan: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
    • 9.2.1.3.2 Japan: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content
  • 9.2.1.4 Australia: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.4.1 Australia: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
    • 9.2.1.4.2 Australia: Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content
  • 9.2.1.5 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by State of Finished Product
    • 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market Breakdown, by Content

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Dr. Reddy's Laboratories
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Sun Pharmaceutical Industries Ltd
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Piramal Enterprises Ltd.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 WOCKHARDT
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Cytovance Biologics
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Thermo Fisher Scientific Inc. (Patheon N.V)
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 MabPlex International Ltd
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

The List of Companies - Asia Pacific Pharmaceutical Fill and Finish Outsourcing Market

  • Abbott
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Dr. Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd
  • Piramal Enterprises Ltd.
  • WOCKHARDT
  • Cytovance Biologics
  • Thermo Fisher Scientific Inc. (Patheon N.V)
  • Boehringer Ingelheim International GmbH
  • MabPlex International Ltd
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)